Main, hard to say who’s right but that’s one of the reasons there’s so much angst on this board. Folks like you and I would be happy at $8-$10 (though of course I would prefer more) but others haven’t averaged down over time, and as such, their respective break even price is much higher.
Main; I tend to agree with Stockboy. Vascepa has more value than most people think it does. Once the tide changes, look out. I’ve got no facts (jump on it Meowza)…,
Like Statins, EPA will become a household word. Name Brands don’t go away. Vascepa will always be the “Gold Standard.”
Whoever buys us, I hope they issue stock because I want to be invested in whoever takes over “Brand Name Vascepa!”
I think at this point Denner would pee himself over a double on his money.
If somebody sees a path to a market cap over $4bn here I'd like to see the math.
You get to $2bn in worldwide sales (which would be incredible) and you have 5-7 years left of exclusivity/maybe patent runway... getting $4bn for that would be pretty impressive.
News 
Market Data 
Discover 
